What is the CTN?
A3. The National Drug Abuse Treatment Clinical Trials Network (CTN) is a unique alliance of community-based drug abuse treatment programs (community treatment programs – CTPs) and investigators in research centers and universities (regional research and training centers- RRTCs) located across the nation and organized into distinct functional units called Nodes. The Clinical Trials Network’s (CTN) multi-site clinical trials provide a valuable resource for accessing diverse patient populations, modalities, and clinical treatment sites. The filtered data set (i.e., without the information that can be used to identify individuals) is housed at a repository contracted by NIDA. These data are kept confidential to the extent permitted by Federal law and no information is disclosed except to NIDA, or pursuant to NIDA’s explicit direction as a result of publications. No individual study site analyses or publications on main outcome measures are permitted prior to publication of the main study f
Related Questions
- How does a sponsor know whether to submit a notification (CTN) or application (CTX) to the Therapeutic Goods Administration (TGA) in Australia?
- Is payment required for TGA notification (CTN) or approval (CTX) and HREC approval in Australia?
- What is NIDAs Drug Abuse Treatment Clinical Trials Network (CTN)?
